Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Al-Saiedy, E. Nelson, T. El-Mays, M. Amrein, F. Green (Calgary, Canada). Perflubron enhances mucin plug clearance in vitro in the presence of natural surfactant. Eur Respir J 2013; 42: Suppl. 57, 686

Member's Comments

No comment yet.

Related content which might interest you: The effect of oligomeric proanthocyanidin on airway microenvironment in asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Two-compartment model of gas mixing in patients with asthma and cystic fibrosis Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Assessment of ATP degradation in bronchoalveolar lavage fluid Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Impaired synthesis and transport of immunoglobulin A in severe asthma: Role of IL-13 Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Vessel tome regulating function of endothelium in patients with bronchial asthma Source: Annual Congress 2013 –Asthma Year: 2013 MIP-1β is associated with eosinophilic airway inflammation Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Smoking alters alpha1-antitrypsin in alveolar macrophages possibly promoting misfolding Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Pulmonary Disease in Pregnancy (Asthma, CF, TB etc.) Source: Respipedia Article Year: 2018 Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Lung function decline in COPD in relation to MMP-12 and surfactant protein A Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 An extensive function evaluation in severe asthma with airflow limitation Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Expression of mRNA chemokine and their receptors in nasopharingeal brush-biopsies represents age of bronchial asthma patients Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Aerobic exercise training reduces asthma phenotype via inhibition of accumulation of extracellular ATP mediated by P2X7 receptor Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014